TherapeuticsMD, Inc. Net Income Loss

• TherapeuticsMD, Inc. showed an increase of +73.9% in Net Income Loss from 2024 to 2025.
• This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), TherapeuticsMD, Inc.'s Net Income Loss has grown by 80.2%.
• Historical annual values: Fiscal year 2025: -$569.0 thousand | Fiscal year 2024: -$2.18 million | Fiscal year 2023: -$10.28 million | Fiscal year 2022: $112.00 million | Fiscal year 2021: -$172.42 million | Fiscal year 2020: -$183.52 million | Fiscal year 2019: -$176.15 million | Fiscal year 2018: -$132.62 million | Fiscal year 2017: -$76.93 million | Fiscal year 2016: -$89.88 million | Fiscal year 2015: -$85.08 million | Fiscal year 2014: -$54.22 million | Fiscal year 2013: -$28.42 million | Fiscal year 2012: -$35.12 million | Fiscal year 2011: -$12.91 million | Fiscal year 2010: -$2.87 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026